secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2026-07-31T12:15:40+00:00
Accession:  0001628280-26-051240
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed Q2 revenue flat at $20.5M, EPS down; declares $0.20 dividend; reaffirms FY guidance
--------------------------------------------------------------------------------

- Q2 revenue $20.5M (+0.5% YoY); GAAP EPS $0.41 (down from $0.45); non-GAAP EPS $0.46 (down from $0.49).
- Declared quarterly cash dividend of $0.20 per share, payable Aug 28, 2026 to holders of record Aug 14.
- Reaffirmed FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.09-2.24.
- Launched next-gen 3870 MR IV pump; initial shipments met plan; domestic monitor unit bookings set record.
- Q3 2026 guidance: revenue $23-24.5M, GAAP EPS $0.49-0.54, non-GAAP EPS $0.54-0.59.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/0001628280-26-051240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/irmd-20260731.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-051240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer